Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Opaleye Management Inc. sold 28,315 Eton Pharmaceuticals, Inc. shares (Form 4/A)
Traded Jul 14, 2026 · Filed Jul 17, 2026
On Jul 14, 2026, Opaleye Management Inc. (10% owner) sold 28,315 Eton Pharmaceuticals, Inc. shares at US$37.54 for US$1.06M, leaving 40,000 shares. Filed Jul 17, 2026 (Form 4/A).
- Sold
- 28,315 shares
- Price
- US$37.54
- Value
- US$1.06M
- Holding after
- 40,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock, par value $0.001 per share | Sale | 15,000 | US$37.54 | 2,665,000 | Indirect |
| Jul 14, 2026 | Common Stock, par value $0.001 per share | Sale | 13,315 | US$37.54 | 40,000 | Indirect |
Source
Related
- Eton Pharmaceuticals, Inc.
- Opaleye Management Inc.
- Eton Pharmaceuticals, Inc. shareholders
- Form 4 · Opaleye Management Inc. · Jul 7, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026